Effect of PKC412, a selective inhibitor of protein kinase C, on lung metastasis in mice injected with B16 melanoma cells

This publication has 15 references indexed in Scilit:

• Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C
  Journal of Clinical Oncology, 2001
• Inhibitors of Protein KinasesCGP 41251, a Protein Kinase Inhibitor with Potential as an Anticancer Agent
  Pharmacology & Therapeutics, 1999
• The Sevenfold Way of PKC Regulation
  Cellular Signalling, 1998
• The potential for isoenzyme‐selective modulation of protein kinase C
  The FASEB Journal, 1997
• Chemosensitization of cancer cells by the staurosporine derivative CGP 41251 in association with decreased P-glycoprotein phosphorylation
  Biochemical Pharmacology, 1997
• Activation of protein kinase C-α isoform in murine melanoma cells with high metastatic potential
  Clinical & Experimental Metastasis, 1997
• The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance
  International Journal of Cancer, 1994
• Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
  Science, 1992
• A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activity
  International Journal of Cancer, 1989
• Selection of Successive Tumour Lines for Metastasis
  Nature New Biology, 1973